TrialThe oncologist2024

Efficacy and safety of camrelizumab, apatinib, and capecitabine combination therapy in advanced biliary tract cancer: a phase 2, nonrandomized, prospective study.

Chao Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.